Sunstone Health & Wellness, Inc. | |
1700 W Smith Valley Rd Ste B4 Greenwood IN 46142-1589 | |
(317) 886-1000 | |
Not Available |
Full Name | Sunstone Health & Wellness, Inc. |
---|---|
Speciality | Community/Behavioral Health |
Location | 1700 W Smith Valley Rd Ste B4, Greenwood, Indiana |
Authorized Official Name and Position | Lacey J. Rentschler (OWNER) |
Authorized Official Contact | 3178861000 |
Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
Mailing Address | Practice Location Address |
---|---|
Sunstone Health & Wellness, Inc. 1700 W Smith Valley Rd Ste B4 Greenwood IN 46142-1589 Ph: (317) 886-1000 | Sunstone Health & Wellness, Inc. 1700 W Smith Valley Rd Ste B4 Greenwood IN 46142-1589 Ph: (317) 886-1000 |
NPI Number | 1275920399 |
---|---|
Provider Enumeration Date | 04/16/2015 |
Last Update Date | 04/16/2015 |
Medicare PECOS PAC ID | 1355630682 |
---|---|
Medicare Enrollment ID | O20160510001081 |
News Archive
Colorcon, Inc. today announced the acquisition of the full-service pharmaceutical excipient company, NP Pharm, a Division of Ethypharm. This acquisition expands Colorcon's global excipient product offerings in the pharmaceutical and nutritional markets.
A new clinical research study at Roswell Park Cancer Institute (RPCI) will assess the safety and efficacy of a novel immunotherapy approach to treating advanced melanoma. Developed at RPCI by Roswell Park researchers, the investigational vaccine shows promise for treating tumors in patients with stage III/stage IV melanoma, and perhaps as a future therapy for other solid-tumor cancers as well.
NovaDigm Therapeutics, a company developing innovative vaccines for fungal and bacterial infections, today announced the presentation of positive data from a preclinical study evaluating the efficacy its NDV-3 vaccine in a model of vulvovaginal candidiasis (VVC), which is primarily caused by Candida albicans.
The hearings represent the first of what will likely be a long list of hearings and new legislation designed to question and denounce the new health law. With the measure in the spotlight, the debate surrounding its fiscal impact also is a "hot topic." Meanwhile, some Democrats who last year opposed the health overhaul are starting to find value in it.
› Verified 1 days ago
Identifier | Type | State | Issuer |
---|---|---|---|
1275920399 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
251S00000X | Community/behavioral Health | 34006187A (Indiana) | Primary |
Provider Name | Michelle G Luallen |
---|---|
Provider Type | Practitioner - Clinical Social Worker |
Provider Identifiers | NPI Number: 1619399557 PECOS PAC ID: 4789809336 Enrollment ID: I20140723000653 |
News Archive
Colorcon, Inc. today announced the acquisition of the full-service pharmaceutical excipient company, NP Pharm, a Division of Ethypharm. This acquisition expands Colorcon's global excipient product offerings in the pharmaceutical and nutritional markets.
A new clinical research study at Roswell Park Cancer Institute (RPCI) will assess the safety and efficacy of a novel immunotherapy approach to treating advanced melanoma. Developed at RPCI by Roswell Park researchers, the investigational vaccine shows promise for treating tumors in patients with stage III/stage IV melanoma, and perhaps as a future therapy for other solid-tumor cancers as well.
NovaDigm Therapeutics, a company developing innovative vaccines for fungal and bacterial infections, today announced the presentation of positive data from a preclinical study evaluating the efficacy its NDV-3 vaccine in a model of vulvovaginal candidiasis (VVC), which is primarily caused by Candida albicans.
The hearings represent the first of what will likely be a long list of hearings and new legislation designed to question and denounce the new health law. With the measure in the spotlight, the debate surrounding its fiscal impact also is a "hot topic." Meanwhile, some Democrats who last year opposed the health overhaul are starting to find value in it.
› Verified 1 days ago
Provider Name | Lacey J Rentschler-miller |
---|---|
Provider Type | Practitioner - Clinical Social Worker |
Provider Identifiers | NPI Number: 1508253543 PECOS PAC ID: 9234428566 Enrollment ID: I20160510001200 |
News Archive
Colorcon, Inc. today announced the acquisition of the full-service pharmaceutical excipient company, NP Pharm, a Division of Ethypharm. This acquisition expands Colorcon's global excipient product offerings in the pharmaceutical and nutritional markets.
A new clinical research study at Roswell Park Cancer Institute (RPCI) will assess the safety and efficacy of a novel immunotherapy approach to treating advanced melanoma. Developed at RPCI by Roswell Park researchers, the investigational vaccine shows promise for treating tumors in patients with stage III/stage IV melanoma, and perhaps as a future therapy for other solid-tumor cancers as well.
NovaDigm Therapeutics, a company developing innovative vaccines for fungal and bacterial infections, today announced the presentation of positive data from a preclinical study evaluating the efficacy its NDV-3 vaccine in a model of vulvovaginal candidiasis (VVC), which is primarily caused by Candida albicans.
The hearings represent the first of what will likely be a long list of hearings and new legislation designed to question and denounce the new health law. With the measure in the spotlight, the debate surrounding its fiscal impact also is a "hot topic." Meanwhile, some Democrats who last year opposed the health overhaul are starting to find value in it.
› Verified 1 days ago
News Archive
Colorcon, Inc. today announced the acquisition of the full-service pharmaceutical excipient company, NP Pharm, a Division of Ethypharm. This acquisition expands Colorcon's global excipient product offerings in the pharmaceutical and nutritional markets.
A new clinical research study at Roswell Park Cancer Institute (RPCI) will assess the safety and efficacy of a novel immunotherapy approach to treating advanced melanoma. Developed at RPCI by Roswell Park researchers, the investigational vaccine shows promise for treating tumors in patients with stage III/stage IV melanoma, and perhaps as a future therapy for other solid-tumor cancers as well.
NovaDigm Therapeutics, a company developing innovative vaccines for fungal and bacterial infections, today announced the presentation of positive data from a preclinical study evaluating the efficacy its NDV-3 vaccine in a model of vulvovaginal candidiasis (VVC), which is primarily caused by Candida albicans.
The hearings represent the first of what will likely be a long list of hearings and new legislation designed to question and denounce the new health law. With the measure in the spotlight, the debate surrounding its fiscal impact also is a "hot topic." Meanwhile, some Democrats who last year opposed the health overhaul are starting to find value in it.
› Verified 1 days ago
Supportive Care Aba In Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 3209 W Smith Valley Rd, Greenwood, IN 46142 Phone: 317-936-1240 Fax: 317-936-1241 | |
Mindful Mood Therapy Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 420 E Main St, Greenwood, IN 46143 Phone: 317-709-8075 | |
Taking Time Therapy Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 70 E Main St Ste J, Greenwood, IN 46143 Phone: 317-883-9391 | |
Breaking Walls Counseling Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 1079 Woodfield Ct, Greenwood, IN 46143 Phone: 317-701-3384 Fax: 317-869-4398 | |
Concepts In Healing, Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 310 W Main St Ste 203, Greenwood, IN 46142 Phone: 317-279-5165 | |
Calming Connections Counseling Llc Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 859 Riverside Dr, Greenwood, IN 46142 Phone: 317-360-0650 Fax: 317-742-9755 | |
Transformations Counseling Services Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 390 N Madison Ave Ste 201, Greenwood, IN 46142 Phone: 317-557-5091 |